APA (7th ed.) Citation

Noor, N. M., Davies, N., Tahir, W., Bond, S., Dowling, F., Patel, K. V., . . . Group, P. S. (2025). Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: A cost-effectiveness analysis from the PROFILE trial. Journal of Crohn's & Colitis, 19(9), 1. https://doi.org/10.1093/ecco-jcc/jjaf150

Chicago Style (17th ed.) Citation

Noor, Nurulamin M., et al. "Anti-tumor Necrosis Factor Treatment from Diagnosis Is More Effective and Less Costly than Conventional "Step-up" Care for Patients with Active Crohn's Disease: A Cost-effectiveness Analysis from the PROFILE Trial." Journal of Crohn's & Colitis 19, no. 9 (2025): 1. https://doi.org/10.1093/ecco-jcc/jjaf150.

MLA (9th ed.) Citation

Noor, Nurulamin M., et al. "Anti-tumor Necrosis Factor Treatment from Diagnosis Is More Effective and Less Costly than Conventional "Step-up" Care for Patients with Active Crohn's Disease: A Cost-effectiveness Analysis from the PROFILE Trial." Journal of Crohn's & Colitis, vol. 19, no. 9, 2025, p. 1, https://doi.org/10.1093/ecco-jcc/jjaf150.